Research analysts covering NewGenIvf Group.
Recent press releases and 8-K filings for NIVF.
NewGenIvf Group Reports Nine-Month 2025 Results and Strategic Acquisitions
NIVF
Earnings
M&A
New Projects/Investments
- NewGenIvf Group Limited reported net income attributable to shareholders of $17.5 million and basic earnings per share of $96.76 for the nine months ended September 30, 2025, a significant improvement from a net loss in the prior year.
- The company's net book value per share improved to $66.75 as of September 30, 2025, from a negative net book value at December 31, 2024, reflecting a balance sheet transformation driven by strategic acquisitions.
- This financial improvement was primarily due to non-cash bargain purchase gains of $23.44 million recognized from the acquisitions of MicroSort® and Nodexus businesses, aligning with its pivot to a technology-licensing model.
- NewGenIvf is diversifying its portfolio, including a plan to invest up to $30 million in Solana (SOL) and securing a 60% ownership interest in a UAE real estate joint venture.
- The company's Board authorized a $2 million share repurchase program in November 2025, following a one-for-five reverse stock split that became effective on December 1, 2025.
Dec 2, 2025, 1:01 PM
NewGenIVF Group Limited Announces US$2 Million Share Repurchase Program
NIVF
Share Buyback
New Projects/Investments
- NewGenIVF Group Limited's Board of Directors has authorized a share repurchase program for up to US$2 million of its outstanding Class A ordinary shares.
- The program is slated to be executed over the next 24 months.
- The authorized repurchase amount represents more than 50% of NewGen's current market capitalization.
- Management believes the current market valuation does not reflect the intrinsic value of the business and its growth trajectory, and the program will be funded using existing cash reserves.
Nov 10, 2025, 1:30 PM
NewGenIvf Group's Subsidiary, NewGenDigital, Appointed as SAXA Inc.'s Agent for Gold-Backed Asset Tokenization
NIVF
New Projects/Investments
M&A
Revenue Acceleration/Inflection
- NewGenIvf Group Limited's subsidiary, NewGenDigital Limited, has been appointed as the worldwide agent for SAXA, Inc. to tokenize an initial US$100 million tranche of gold-backed assets, with provisions to expand up to US$1 billion.
- NewGenDigital will earn a 5% commission on the tokenized assets sold, representing a potential revenue opportunity of up to US$5 million for the initial tranche.
- This agreement, effective October 30, 2025, is the first part of a two-part transaction, intended to support and facilitate a proposed reverse merger between NewGen and SAXA, details of which were announced on November 3, 2025.
Nov 5, 2025, 3:24 PM
NewGenIvf Group Limited Reports Interim Results for Six Months Ended June 30, 2025
NIVF
Earnings
M&A
New Projects/Investments
- NewGenIvf Group Limited reported net income attributable to shareholders of $724,975 on revenue of $2,019,628 for the six months ended June 30, 2025, compared to a net loss of ($396,543) in the prior year period.
- The company's financial performance was significantly impacted by a bargain purchase gain of $4,276,500 recognized from the acquisition of MicroSort Reproductive Technology.
- A fair value gain of $0.1 million was recognized on the revaluation of the company's SOL token holdings, which were valued at approximately $3.16 million as of September 15, 2025.
Oct 9, 2025, 11:42 AM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more